Olivier Godinant, mentioned 15 times across podcast episodes and expert conversations analyzed by Sonic.
OpenAI is working with healthcare company Amgen to accelerate its drug development and commercialization processes.
Olivier Godinant identifies the November 2023 ouster of CEO Sam Altman by the board, an event internally referred to as 'the blip,' as the toughest moment in his OpenAI journey.
At OpenAI, product managers have shifted from writing traditional Product Requirement Documents (PRDs) to 'vibe coding' functional prototypes using tools like GPT-5 and Codex.